New diabetes drug BGM0504 takes on semaglutide in major trial
NCT ID NCT07064486
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 24 times
Summary
This study tests a new medicine called BGM0504 against the well-known drug semaglutide (like Ozempic) in people with type 2 diabetes. All participants take metformin and then get either BGM0504 or semaglutide once a week. The goal is to see which works better at lowering blood sugar and body weight over 24 weeks. About 477 adults in Indonesia are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RS Universitas Indonesia
RECRUITINGDepok, West Java, Indonesia
-
RSUP Fatmawati
RECRUITINGJakarta, Indonesia
-
RSUP Persahabatan
RECRUITINGJakarta, Indonesia
-
RSUPN Dr. Cipto Mangunkusumo
RECRUITINGJakarta, Indonesia
Conditions
Explore the condition pages connected to this study.